CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	12 Months Ended
Apr. 30, 2020	Apr. 30, 2019
Revenues:
Revenue	$ 0	$ 0
Operating Expenses:
Research and development costs	301,221	460,052
Compensation expense	1,586,583	1,555,258
Director fees	316,892	406,812
Legal and professional fees	459,146	299,963
General and administrative	1,162,553	1,378,544
Total operating expenses	3,826,395	4,100,629
Loss from operations	(3,826,395)	(4,100,629)
Other income (expense):
Interest expense	(453)	0
Other income (expense)	(40)	33,401
Total other income (expense), net	(493)	33,401
Net loss	$ (3,826,888)	$ (4,067,228)
Basic and diluted loss per share	$ 0.00	$ 0.00
Weighted average shares outstanding basic and diluted	1,355,717,271	1,100,104,338

The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256